Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
diabetes drug
Biotech
FDA lifts diabetes hold after Biomea mitigates liver tox risk
The regulator has cleared Biomea to study its diabetes drug candidate under a revised protocol intended to mitigate liver toxicity concerns.
Nick Paul Taylor
Sep 27, 2024 7:10am
Novo Nordisk axes once-monthly GLP-1/GIP agonist MASH prospect
Aug 7, 2024 7:00am
Diabetes biotech stock tanks as FDA imposes full clinical hold
Jun 7, 2024 8:13am
A 'live fire exercise' with COVID preps SAB for new (old) focus
Oct 16, 2023 6:00am
Lilly brushes off liver tox worries as Pfizer drops obesity drug
Aug 8, 2023 10:51am
Lilly's next obesity drug just cut an average of 58 pounds
Jun 26, 2023 8:45pm
